ENTITY
Betta Pharmaceuticals

Betta Pharmaceuticals (300558 CH)

56
Analysis
Health Care • China
Betta Pharmaceuticals Co., Ltd operates as a pharmaceutical company. The Company researches, manufactures, and sells drugs for the treatment of malignant tumors, diabetes, cardiovascular, cerebrovascular, and other related diseases. Betta Pharmaceuticals markets throughout China.
more
•08 Dec 2020 09:23

Pre-IPO Jacobio Pharmaceuticals - Insights on Pipeline

This article analyzed the compelling and distinctive pipeline of Jacobio Pharmaceuticals in terms of projects. Meanwhile, it also disclose the...

Logo
505 Views
Share
•22 Nov 2020 09:33

China Healthcare Weekly (Nov. 20)

The article summarized the new healthcare policy released, major industry viewpoints, company news and capital market review in China healthcare...

Logo
353 Views
Share
•28 Oct 2020 10:31

Jiangsu Hengrui Medicine (600276 CH) - Q3 Performance Improved with Promising Innovative Pipeline

This article analyzed Hengrui's Q3 performance, strengths in innovation, promotion and internationalization, as well as its forecast and rating.

Logo
466 Views
Share
•21 Oct 2020 02:00

Jacobio Pharma: Focus on Novel Targets

An in-depth overview of the proposed listing of Jacobio Pharmaceuticals using a framework that touches on the science, market opportunity,...

Share
•07 Oct 2020 10:06

Betta Pharmaceuticals (300558.SZ) -Ā The Harvest Season Is Coming

Icotinib hydrochloride ensures stable cash flow for Betta for years.Ā Icotinib hydrochloride is a National Class 1.1 new drug that is independently...

Logo
447 Views
Share
x